NEJM介绍两项遗传病基因治疗进展:2025年5月简报报道一例为尿素循环障碍婴儿定制设计的脂质纳米颗粒递送碱基编辑疗法;2026年4月"基础研究临床意义"文章综述通过单次基因编辑克服不同基因无义突变影响的新思路,类似"一药多治"模式。
A Brief Report published in May of 2025 describes a lipid nanoparticle–delivered base-editing therapy that was custom designed for an infant with a urea-cycle disorder. A Clinical Implications of Basic Research published in April 2026 reviews another approach to genetic therapy: how a single genetic edit can overcome the effect of nonsense variants in different genes, akin to a one-size-fits-many model.
📖 Further reading:
Brief Report: Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease https://nej.md/42XF03F
Clinical Implications of Basic Research: Editing tRNA Genes to Broaden Nonsense Therapeutics https://nej.md/4ttIiXg
来源:NEJM · x.com